0001214659-21-010213.txt : 20211004 0001214659-21-010213.hdr.sgml : 20211004 20211004200551 ACCESSION NUMBER: 0001214659-21-010213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kilcoyne Adrian CENTRAL INDEX KEY: 0001857963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 211304743 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-53962.xml PRIMARY DOCUMENT X0306 4 2021-09-30 0001293310 HUMANIGEN, INC HGEN 0001857963 Kilcoyne Adrian C/O HUMANIGEN, INC. 533 AIRPORT BLVD., SUITE 400 BURLINGAME CA 94010 false true false false Chief Medical Officer Stock Option (Right to Buy) 5.93 2021-09-30 4 A false 5863 0 A 2021-10-31 2031-09-30 Common Stock 5863 5863 D This stock option was granted to the reporting person in lieu of 25% of his base salary for the fourth quarter of 2021. The option vests in three ratable installments on each of October 31, 2021, November 30, 2021 and December 31, 2021. /s/ Timothy Morris, Attorney-in-Fact 2021-10-04